{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:45:17Z","timestamp":1787939117009,"version":"build-2784847793"},"reference-count":37,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873758"],"award-info":[{"award-number":["81873758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Limb\u2013girdle muscular dystrophy R2 (LGMD R2) is most frequently misdiagnosed as immune-mediated necrotizing myopathy (IMNM). This study aimed to compare the clinicopathological data of IMNM and LGMD R2 to find distinguishing features. Methods: We retrospectively reassessed the medical data of patients with IMNM (n = 41) and LGMD R2 (n = 8) treated at Tongji Hospital from January 2017 to December 2021. Results: In our cohort, patients with LGMD R2 had a longer interval of onset to first visit, mild muscle weakness with late upper limb involvement, less myalgia, no cervical muscle weakness or dysphagia, no extramuscular organs affected except cardiac involvement, and lack of various autoantibodies, such as antinuclear antibodies. These features were completely reversed in IMNM. Moreover, thigh MRIs showed that muscle edema prominently affecting the adductor magnus was a characteristic of IMNM, while extensive fatty replacement was more common in LGMD R2 (p = 0.0086). Necrotic myofibers presented in both entities (p = 0.1693), while features such as ring\/whorled and splitting myofibers were more often found in LGMD R2 (p = 0.0112 and p &lt; 0.0001, respectively). Conversely, sarcoplasmic p62 expression was more pronounced in IMNM (p &lt; 0.05). There were 4 of 8 (50%) patients with LGMD R2 initially considered as seronegative IMNM, and therefore unnecessarily treated with immunosuppressive drugs. Insufficient recognition of the early clinical, imaging, and histopathological features of LGMD R2 is the main reason for misdiagnosis. Conclusions: These findings may help clinicians differentiate seronegative IMNM and LGMD R2, reducing early misdiagnosis and mismanagement. Particularly, prominent adductor magnus edema on MRI and abundant p62 staining seem to be good markers for IMNM, while the presence of splitting myofibers is a crucial clue to early hereditary myopathy, including LGMD R2.<\/jats:p>","DOI":"10.3390\/jcm11216566","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T08:52:56Z","timestamp":1667897576000},"page":"6566","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Clinicopathological Distinction between Immune-Mediated Necrotizing Myopathy and Limb\u2013Girdle Muscular Dystrophy R2: Key Points to Prevent Misdiagnosis"],"prefix":"10.3390","volume":"11","author":[{"given":"Mengge","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Neurology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suqiong","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajie","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitao","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: Clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/BOR.0000000000000836","article-title":"Differential diagnosis of necrotizing myopathy","volume":"33","author":"Milisenda","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102993","DOI":"10.1016\/j.autrev.2021.102993","article-title":"Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge","volume":"21","author":"Merlonghi","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2044-5040-1-10","article-title":"Muscle membrane repair and inflammatory attack in dysferlinopathy","volume":"1","author":"Han","year":"2011","journal-title":"Skelet. Muscle"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/mus.25367","article-title":"Progress and challenges in diagnosis of dysferlinopathy","volume":"54","author":"Fanin","year":"2016","journal-title":"Muscle Nerve"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13023-020-01445-1","article-title":"Clinical, pathological, imaging, and genetic characterization in a Taiwanese cohort with limb-girdle muscular dystrophy","volume":"15","author":"Liang","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jnnp-2011-301339","article-title":"Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B","volume":"84","author":"Takahashi","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: Clinico-sero-pathological classifi-cation of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul. Disord"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00415-019-09539-y","article-title":"European muscle MRI study in limb girdle muscular dystrophy type R1\/2A (LGMDR1\/LGMD2A)","volume":"267","author":"Barp","year":"2020","journal-title":"J. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneur.64.8.1176","article-title":"Phenotypic study in 40 patients with dysferlin gene mutations: High frequency of atypical phenotypes","volume":"64","author":"Nguyen","year":"2007","journal-title":"Arch. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXG.0000000000000089","article-title":"The Clinical Outcome Study for dysferlinopathy: An international multicenter study","volume":"2","author":"Harris","year":"2016","journal-title":"Neurol Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2018.09.008","article-title":"Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy","volume":"18","author":"Anquetil","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_13","first-page":"938","article-title":"Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)","volume":"45","author":"Aoki","year":"2005","journal-title":"Rinsho Shinkeigaku Clin. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.mayocp.2020.03.032","article-title":"Cardiac and Respiratory Complications of Necrotizing Autoimmune Myopathy","volume":"95","author":"Triplett","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ma, X., Xu, L., Li, Y., and Bu, B. (2021). Immunotherapy reversed myopathy but not cardiomyopathy in a necrotizing autoimmune myopathy patient with positive anti-SRP and MDA-5 autoantibodies. BMC Cardiovasc. Disord., 21.","DOI":"10.1186\/s12872-021-01900-2"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"670784","DOI":"10.3389\/fneur.2021.670784","article-title":"The Clinicopathological Distinction Between Seropositive and Seronegative Immune-Mediated Ne-crotizing Myopathy in China","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Neurol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00109-007-0253-7","article-title":"Dysfunction of dysferlin-deficient hearts","volume":"85","author":"Wenzel","year":"2007","journal-title":"J. Mol. Med."},{"key":"ref_18","first-page":"39","article-title":"Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dys-trophy 2B and 2I","volume":"13","author":"Rosales","year":"2011","journal-title":"J. Cardiovasc. Magn. Reson. Off. J. Soc. Cardiovasc. Magn. Reson."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/mus.24741","article-title":"Respiratory and cardiac function in japanese patients with dysferli-nopathy","volume":"53","author":"Nishikawa","year":"2016","journal-title":"Muscle Nerve"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keab553","article-title":"Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: Key points to prevent misdiagnosis","volume":"61","author":"Marago","year":"2021","journal-title":"Rheumatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"783095","DOI":"10.3389\/fneur.2021.783095","article-title":"A Muscle Biosignature Differentiating Between Limb-Girdle Muscular Dystrophy and Idiopathic Inflammatory Myopathy on Magnetic Resonance Imaging","volume":"12","author":"Hsu","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s13311-018-0648-x","article-title":"The Limb-Girdle Muscular Dystrophies: Is Treatment on the Horizon?","volume":"15","author":"Chu","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","article-title":"Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy","volume":"6","author":"Mohassel","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0037-1604402","article-title":"Anti-HMGCR Antibody-Related Necrotizing Autoimmune Myopathy Mimicking Mus-cular Dystrophy","volume":"48","author":"Tard","year":"2017","journal-title":"Neuropediatrics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/mus.25567","article-title":"Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child","volume":"56","author":"Mohassel","year":"2017","journal-title":"Muscle Nerve"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.semarthrit.2019.04.002","article-title":"Immune-mediated necrotising myopathy: A critical review of current concepts","volume":"49","author":"Day","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"C724","DOI":"10.1152\/ajpcell.00348.2016","article-title":"Ulk1-mediated autophagy plays an essential role in mitochondrial remodeling and functional regeneration of skeletal muscle","volume":"312","author":"Call","year":"2017","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lee, D.E., Bareja, A., Bartlett, D.B., and White, J.P. (2019). Autophagy as a Therapeutic Target to Enhance Aged Muscle Regeneration. Cells, 8.","DOI":"10.3390\/cells8020183"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.nmd.2012.03.002","article-title":"Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflam-matory response","volume":"22","author":"Cohen","year":"2012","journal-title":"Neuromuscul. Disord. NMD"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"112906","DOI":"10.1016\/j.yexcr.2021.112906","article-title":"Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies","volume":"411","author":"Ganassi","year":"2022","journal-title":"Exp. Cell Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mus.26608","article-title":"Autophagy markers LC3 and p62 accumulate in immune-mediated necrotizing myopathy","volume":"60","author":"Girolamo","year":"2019","journal-title":"Muscle Nerve"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nmd.2011.04.006","article-title":"172nd ENMC International Workshop: Dysferlinopathies 29\u201331 January 2010, Naarden, The Netherlands","volume":"21","author":"Krahn","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lerario, A., Cogiamanian, F., Marchesi, C., Belicchi, M., Bresolin, N., Porretti, L., and Torrente, Y. (2010). Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy. BMC Musculoskelet. Disord., 11.","DOI":"10.1186\/1471-2474-11-157"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-8-26","article-title":"Treatment of dysferlinopathy with deflazacort: A double-blind, placebo-controlled clinical trial","volume":"8","author":"Walter","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Yu, M., Zheng, Y., Jin, S., Gang, Q., Wang, Q., Yu, P., Lv, H., Zhang, W., Yuan, Y., and Wang, Z. (2017). Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175343"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40478-022-01320-z","article-title":"The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies","volume":"10","author":"Becker","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neulet.2017.10.048","article-title":"Novel, de novo dysferlin gene mutations in a patient with Miyoshi myopathy","volume":"664","author":"Hu","year":"2018","journal-title":"Neurosci. Lett."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/21\/6566\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:11:07Z","timestamp":1760145067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/21\/6566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,5]]},"references-count":37,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["jcm11216566"],"URL":"https:\/\/doi.org\/10.3390\/jcm11216566","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,5]]}}}